pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Dermatology · news · pharmadog
← back to Dermatology
News · Dermatology
112
stories
Jun 2, 26
AbiVax falls as safety worries cloud ‘landmark’ immune drug results
biopharma dive
May 29, 26
Replimune takes third swing at cancer drug approval following ‘productive’ FDA talks
biopharma dive
May 18, 26
Regeneron's Phase 3 skin cancer miss adds to mounting failures in LAG-3
endpoints
May 12, 26
Dr Postow on an Ideal Post-ICI Monitoring Framework in Melanoma
onclive
May 11, 26
No FDA permission, no problem: New flavored vape policy worries experts
stat
May 11, 26
The connection between periods and mental health
stat
May 11, 26
Animal skin disease confirmed in clusters of European men who have sex with men
stat
May 10, 26
Five Under 5: Top Oncology Videos for the Week of 5/3
onclive
May 8, 26
FDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extended
biopharma dive
May 6, 26
Avalo scores Phase 2 success in comeback bid, raises $375M
endpoints
May 6, 26
Avalo shares spike on skin drug data; BioNTech to cut staff
biopharma dive
May 5, 26
Viridian data lift prospects for thyroid eye disease drug
biopharma dive
May 4, 26
Celcuity strengthens case for ASCO-spotlighted breast cancer drug
biopharma dive
May 2, 26
Opinion: What do medical students think about their education?
stat
Apr 30, 26
Supreme Court questions how far generics makers can go with 'skinny label' drugs
endpoints
Apr 30, 26
Opinion: Are international medical graduates taking residency spots from Americans? We did the math
stat
Apr 28, 26
Incyte claims double Phase 3 win in vitiligo, will file for approval
endpoints
Apr 27, 26
Oruka surges as long-acting psoriasis drug shows early promise
biopharma dive
Apr 27, 26
Veradermics soars on positive data for baldness treatment
biopharma dive
Apr 27, 26
Oruka posts Phase 2 win in psoriasis, hoping to compete with Skyrizi
endpoints
Apr 27, 26
STAT+: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage study
stat
Apr 23, 26
Heart’s beat may help it beat cancer, mouse research suggests
stat
← prev
page 4 of 4
next →
